Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110255132> ?p ?o ?g. }
- W2110255132 endingPage "1038" @default.
- W2110255132 startingPage "1029" @default.
- W2110255132 abstract "Severe forms of primary dystonia are difficult to manage medically. We assessed the safety and efficacy of pallidal neurostimulation in patients with primary generalised or segmental dystonia prospectively followed up for 5 years in a controlled multicentre trial.In the parent trial, 40 patients were randomly assigned to either sham neurostimulation or neurostimulation of the internal globus pallidus for a period of 3 months and thereafter all patients completed 6 months of active neurostimulation. 38 patients agreed to be followed up annually after the activation of neurostimulation, including assessments of dystonia severity, pain, disability, and quality of life. The primary endpoint of the 5-year follow-up study extension was the change in dystonia severity at 3 years and 5 years as assessed by open-label ratings of the Burke-Fahn-Marsden dystonia rating scale (BFMDRS) motor score compared with the preoperative baseline and the 6-month visit. The primary endpoint was analysed on an intention-to-treat basis. The original trial is registered with ClinicalTrials.gov (NCT00142259).An intention-to-treat analysis including all patients from the parent trial showed significant improvements in dystonia severity at 3 years and 5 years compared with baseline, which corresponded to -20·8 points (SD 17·1; -47·9%; n=40) at 6 months; -26·5 points (19·7; -61·1%; n=31) at 3 years; and -25·1 points (21·3; -57·8%; n=32). The improvement from 6 months to 3 years (-5·7 points [SD 8·4]; -34%) was significant and sustained at the 5-year follow-up (-4·3 [10·4]). 49 new adverse events occurred between 6 months and 5 years. Dysarthria and transient worsening of dystonia were the most common non-serious adverse events. 21 adverse events were rated serious and were almost exclusively device related. One patient attempted suicide shortly after the 6-month visit during a depressive episode. All serious adverse events resolved without permanent sequelae.3 years and 5 years after surgery, pallidal neurostimulation continues to be an effective and relatively safe treatment option for patients with severe idiopathic dystonia. This long-term observation provides further evidence in favour of pallidal neurostimulation as a first-line treatment for patients with medically intractable, segmental, or generalised dystonia.Medtronic." @default.
- W2110255132 created "2016-06-24" @default.
- W2110255132 creator A5000556667 @default.
- W2110255132 creator A5002340019 @default.
- W2110255132 creator A5013035262 @default.
- W2110255132 creator A5015932829 @default.
- W2110255132 creator A5016648966 @default.
- W2110255132 creator A5021241375 @default.
- W2110255132 creator A5031810199 @default.
- W2110255132 creator A5034219333 @default.
- W2110255132 creator A5037338326 @default.
- W2110255132 creator A5040286592 @default.
- W2110255132 creator A5041405337 @default.
- W2110255132 creator A5045305373 @default.
- W2110255132 creator A5049406744 @default.
- W2110255132 creator A5054677591 @default.
- W2110255132 creator A5055816568 @default.
- W2110255132 creator A5060040683 @default.
- W2110255132 creator A5065746961 @default.
- W2110255132 creator A5070073995 @default.
- W2110255132 creator A5070448462 @default.
- W2110255132 creator A5083610914 @default.
- W2110255132 creator A5083855931 @default.
- W2110255132 creator A5084697263 @default.
- W2110255132 creator A5085574398 @default.
- W2110255132 date "2012-12-01" @default.
- W2110255132 modified "2023-10-06" @default.
- W2110255132 title "Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial" @default.
- W2110255132 cites W1547539008 @default.
- W2110255132 cites W1867291225 @default.
- W2110255132 cites W1976545284 @default.
- W2110255132 cites W1984242967 @default.
- W2110255132 cites W1984350622 @default.
- W2110255132 cites W1987021216 @default.
- W2110255132 cites W1994303356 @default.
- W2110255132 cites W2008123743 @default.
- W2110255132 cites W2019941448 @default.
- W2110255132 cites W2025624423 @default.
- W2110255132 cites W2030321372 @default.
- W2110255132 cites W2036079744 @default.
- W2110255132 cites W2038316714 @default.
- W2110255132 cites W2064253412 @default.
- W2110255132 cites W2088037244 @default.
- W2110255132 cites W2091046222 @default.
- W2110255132 cites W2104511197 @default.
- W2110255132 cites W2116616124 @default.
- W2110255132 cites W2117271032 @default.
- W2110255132 cites W2117967389 @default.
- W2110255132 cites W2126261892 @default.
- W2110255132 cites W2128319759 @default.
- W2110255132 cites W2171779439 @default.
- W2110255132 cites W2333735581 @default.
- W2110255132 cites W4292806894 @default.
- W2110255132 doi "https://doi.org/10.1016/s1474-4422(12)70257-0" @default.
- W2110255132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23123071" @default.
- W2110255132 hasPublicationYear "2012" @default.
- W2110255132 type Work @default.
- W2110255132 sameAs 2110255132 @default.
- W2110255132 citedByCount "290" @default.
- W2110255132 countsByYear W21102551322012 @default.
- W2110255132 countsByYear W21102551322013 @default.
- W2110255132 countsByYear W21102551322014 @default.
- W2110255132 countsByYear W21102551322015 @default.
- W2110255132 countsByYear W21102551322016 @default.
- W2110255132 countsByYear W21102551322017 @default.
- W2110255132 countsByYear W21102551322018 @default.
- W2110255132 countsByYear W21102551322019 @default.
- W2110255132 countsByYear W21102551322020 @default.
- W2110255132 countsByYear W21102551322021 @default.
- W2110255132 countsByYear W21102551322022 @default.
- W2110255132 countsByYear W21102551322023 @default.
- W2110255132 crossrefType "journal-article" @default.
- W2110255132 hasAuthorship W2110255132A5000556667 @default.
- W2110255132 hasAuthorship W2110255132A5002340019 @default.
- W2110255132 hasAuthorship W2110255132A5013035262 @default.
- W2110255132 hasAuthorship W2110255132A5015932829 @default.
- W2110255132 hasAuthorship W2110255132A5016648966 @default.
- W2110255132 hasAuthorship W2110255132A5021241375 @default.
- W2110255132 hasAuthorship W2110255132A5031810199 @default.
- W2110255132 hasAuthorship W2110255132A5034219333 @default.
- W2110255132 hasAuthorship W2110255132A5037338326 @default.
- W2110255132 hasAuthorship W2110255132A5040286592 @default.
- W2110255132 hasAuthorship W2110255132A5041405337 @default.
- W2110255132 hasAuthorship W2110255132A5045305373 @default.
- W2110255132 hasAuthorship W2110255132A5049406744 @default.
- W2110255132 hasAuthorship W2110255132A5054677591 @default.
- W2110255132 hasAuthorship W2110255132A5055816568 @default.
- W2110255132 hasAuthorship W2110255132A5060040683 @default.
- W2110255132 hasAuthorship W2110255132A5065746961 @default.
- W2110255132 hasAuthorship W2110255132A5070073995 @default.
- W2110255132 hasAuthorship W2110255132A5070448462 @default.
- W2110255132 hasAuthorship W2110255132A5083610914 @default.
- W2110255132 hasAuthorship W2110255132A5083855931 @default.
- W2110255132 hasAuthorship W2110255132A5084697263 @default.
- W2110255132 hasAuthorship W2110255132A5085574398 @default.
- W2110255132 hasConcept C118552586 @default.
- W2110255132 hasConcept C126322002 @default.
- W2110255132 hasConcept C138496976 @default.